Tracesci Global to present track and trace solution at PharmaTech 2023

The circulation of counterfeit medicine is detrimental to the expansion of the pharma trade, and adopting anti-counterfeiting measures on the manufacturing location is essential. Tracesci advocates for the adoption of blockchain-based monitor and hint options that may present producers with 360 levels visibility and management over their provide chains. 

The pharmaceutical trade has lengthy been dealing with the problem of counterfeit or spurious medicine, and the challenges have solely been exacerbated by the disruptions brought on by the Covid-19 pandemic. 

In keeping with a current report revealed by CRISIL-ASPA on the State of Counterfeiting in India 2022, trade insiders estimate that 0.1-3% of medicines manufactured and offered in India are counterfeit, whereas distributors and authentication answer suppliers imagine the quantity could possibly be as excessive as 10-20% of the general pharmaceutical market.

“With TRACESCI, a model can acquire an efficient product authentication answer that features monitoring professional merchandise all through the availability chain, a client engagement app, and an environment friendly reporting system, all underneath one distinctive SAAS-based monitor and hint platform,” stated Priyanka Rathi, DGM, advertising and marketing and communication at Jetsci World & Tracesci World.

Kunal Kothari, product supervisor at Tracesci World, added, “As a worldwide specialist in product authentication and traceability, we’re efficiently fortifying governments and types alike by means of our intuitive, progressive blockchain-based provide chain producer interface. With Tracesci, traceability is only a faucet away.”